- Home
- RLGT vs BBOT Comparison
RLGT vs BBOT Comparison
Compare RLGT & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | BBOT |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.9M | 442.6M |
| IPO Year | 2006 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RLGT | BBOT |
|---|---|---|
| Price | $8.99 | $2.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $11.00 | ★ $24.55 |
| AVG Volume (30 Days) | 185.6K | ★ 536.1K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.43 | ★ 99.93 |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $934,356,000.00 | N/A |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | $23.26 | ★ N/A |
| Revenue Growth | ★ 3.51 | N/A |
| 52 Week Low | $5.86 | $2.86 |
| 52 Week High | $10.20 | $14.87 |
Technical Indicators
Market Signals| Indicator | RLGT | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 15.24 |
| Support Level | $8.09 | N/A |
| Resistance Level | $9.56 | $9.36 |
| Average True Range (ATR) | 0.24 | 0.24 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 39.78 | 2.99 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services, including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.